Richard Cao is a vascular biology researcher with 12 years of experience bridging clinical medicine and bench science, currently based at Queen’s University. He develops and implements sophisticated in vivo models—most recently a smooth muscle cell–targeted, tamoxifen-inducible Capn4 conditional knockout mouse—to probe mechanisms of atherosclerotic plaque formation and rupture. His prior postdoctoral work at the University of Pennsylvania explored cytokine regulation in allergic airway responses, and his clinical training in Shanghai included tumor immunotherapy and teaching in head and neck oncology. Skilled in molecular biology, vascular imaging, cell culture and diverse animal models, he uniquely combines MD clinical insight with experimental rigor to translate inflammatory mechanisms into potential therapeutic targets.
Find and Hire Top DevelopersWe’ve analyzed the programming source code of over 60 million software developers on GitHub and scored them by 50,000 skills. Sign-up on Prog,AI to search for software developers.